Evidence map›Paper›PMID 25865392›Full record

ReviewOsteoarthritis and cartilage2015

Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.

V B Kraus, F J Blanco, M Englund, M A Karsdal, L S Lohmander

4 registry-linked trialsAbstract readReview
In one paragraph

Review in Osteoarthritis and cartilage, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 293 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
293citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03106584 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Investigating the Potential for Marigot's Nutrition Supplement to Improve Symptoms and Physical Function in Those With Mild to Moderate Knee Osteoarthritis (KOA) Versus the Current Market Leader (Glucosamine Sulphate)

TypeinterventionalSponsorUniversity College DublinRan2017 to 2017Enrolled30ConditionsKnee OsteoarthritisArmsAquamin-Plus, Glucosamine sulphate
NCT04168593 nacompletednot on this mapstarted 2018, after this paper: background citation

Randomized Controlled Trial of the Use of Acupuncture and Cupping in Patients Awaiting Total Knee Arthroplasty (TKA) Due to Knee Osteoarthritis

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2018 to 2020Enrolled120ConditionsKnee Osteoarthritis, Pain, ChronicArmsAcupuncture
NCT07640529 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The ACT-ON: A Geriatric 5-Ms-Guided Physical Therapy Intervention for Knee Osteo-Arthritis in Older Adults: A Randomised Control Trial

TypeinterventionalSponsorKing Saud UniversityRan2026 to 2026Enrolled40ConditionsRehabilitation, Excercise, Geriatric, Physical TherapyArmsGeriatric 5Ms framework, Exercises PT
NCT07692009 phase4completednot on this mapstarted 2024, after this paper: background citation

Efficacy Evaluation of Intraarticular Collagen-polyvinylpyrrolidone (Fibroquel®) vs Hylan G-F 20 (Synvisc®) in the Treatment of Knee Osteoarthritis. A Double-blind, Controlled, Randomised, Parallel-groups, Non-inferiority Study

TypeinterventionalSponsorCentro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan S.Ran2024 to 2026Enrolled32ConditionsOsteoarthritis (OA) of the KneeArmsCollagen-polyvinylpyrrolidone, Hylan G-F 20
3 · Its place in the literature

Who cites it

293 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2021
    Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

233 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

V B KrausDuke Molecular Physiology Institute and Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address: vbk@duke.edu.
F J BlancoGrupo de Proteomica, ProteoRed/ISCIII, Servicio de Reumatologia, Instituto de Investigación Biomedica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), As Xubias, 15006, A Coruña, Spain.
M EnglundOrthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston University, MA, USA.
M A KarsdalNordic Bioscience, Herlev, Denmark.
L S LohmanderOrthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Research Unit for Musculoskeletal Function and Physiotherapy, and Department of Orthopedics and Traumatology, University of Southern Denmark, Odense, Denmark.

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Virginia B Kraus · 2006 to 2026
$24.6M
Thermally-Triggered Intra-articular Drug Delivery for OAP01AR050245 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2012
$11.5M
NIAMS NIH HHS P01 AR050245NIA NIH HHS P30 AG028716
6 · The paper itself

Abstract

Osteoarthritis (OA) is a heterogeneous disorder. The goals of this review are (1) To stimulate use of standardized nomenclature for OA that could serve as building blocks for describing OA and defining OA phenotypes, in short to provide unifying disease concepts for a heterogeneous disorder; and (2) To stimulate establishment of ROAD (Risk of OA Development) and ROAP (Risk of OA Progression) tools analogous to the FRAX™ instrument for predicting risk of fracture in osteoporosis; and (3) To stimulate formulation of tools for identifying disease in its early preradiographic and/or molecular stages - REDI (Reliable Early Disease Identification). Consensus around more sensitive and specific diagnostic criteria for OA could spur development of disease modifying therapies for this entity that has proved so recalcitrant to date. We fully acknowledge that as we move forward, we expect to develop more sophisticated definitions, terminology and tools.

Indexed as

Risk AssessmentTerminology as TopicClinical Trials as TopicDisease ProgressionHealth PromotionHumansOsteoarthritisOsteoporotic FracturesPatient Outcome AssessmentAnatomyBiomarkersCriteriaDefinitionOsteoarthritisPhysiology

Identifiers

PMID25865392
PMCPMC4516635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.